Cite
APA Citation
Tibaldi, C. (2014). research Highlights: Mechanisms of resistance to crizotinib in patients with ALK gene rearranged non-small-cell lung cancer. Pharmacogenomics, 15, 133–135. http://access.bl.uk/ark:/81055/vdc_100140417474.0x00000f